Commodore Capital Lp - Apr 4, 2025 SCHEDULE 13G Report for Viridian Therapeutics, Inc. Common Stock, $0.01 par value per share (VRDN)

Filing Manager: COMMODORE CAPITAL LP
Reporting Manager: Commodore Capital LP
Security: Viridian Therapeutics, Inc. Common Stock, $0.01 par value per share
Symbol: VRDN
Shares outstanding: 81.1M shares
Disclosed Ownership: 4.3M shares
Ownership: 5.3%
Form type: SCHEDULE 13G
Date filed: 4/11/2025, 05:15 PM
Date of event: Apr 4, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Commodore Capital LP	5.3%	4.3M	0	4.3M	/s/ Michael Kramarz	Michael Kramarz, Managing Partner
Commodore Capital Master LP	5.3%	4.3M	0	4.3M	/s/ Michael Kramarz	Michael Kramarz, Authorized Signatory